Longduoduo (LDDD) Net Income towards Common Stockholders (2021 - 2026)
Longduoduo (LDDD) posted quarterly Net Income towards Common Stockholders of -$167896.0 for Q1 2026, down 205.31% year-over-year from $159430.5 in Q1 2025, and up 38.78% quarter-over-quarter from -$274245.0 in Q4 2025.
Longduoduo (LDDD) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Longduoduo's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$167896.0 for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 205.31% year-over-year to -$167896.0; the TTM figure through Mar 2026 stood at -$1.5 million (down 157.09% YoY), while the FY2025 annual figure was -$441882.0, down 128.26% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$167896.0, up from -$274245.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $2.2 million in Q2 2024, with the low at -$961065.0 in Q2 2025.
- The 5-year median for Net Income towards Common Stockholders is -$156923.0 (2022), against an average of $59882.5.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders surged 537.65% in 2023, then sank 321.18% in 2025.
- Longduoduo's Net Income towards Common Stockholders stood at -$156923.0 in 2022, then fell by 13.66% to -$178363.0 in 2023, then surged by 381.22% to $501599.0 in 2024, then tumbled by 154.67% to -$274245.0 in 2025, then soared by 38.78% to -$167896.0 in 2026.
- Business Quant data shows LDDD's Net Income towards Common Stockholders at -$167896.0 in Q1 2026, -$274245.0 in Q4 2025, and -$111182.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Longduoduo | 15.31 Mn | 14.14 Mn | 184,055.00 | -190,007.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -190,007.00 |
| Dec 31, 2025 | -274,245.00 |
| Sep 30, 2025 | -164,080.00 |
| Jun 30, 2025 | 192,691.00 |
| Mar 31, 2025 | -116,320.00 |
| Dec 31, 2024 | 530,327.00 |
| Sep 30, 2024 | -109,952.00 |
| Jun 30, 2024 | 384,565.00 |
| Mar 31, 2024 | 565,990.00 |
| Dec 31, 2023 | 285,118.00 |
| Sep 30, 2023 | 328,120.00 |
| Jun 30, 2023 | 829,289.00 |
| Mar 31, 2023 | -430,807.00 |
| Dec 31, 2022 | -156,923.00 |
| Sep 30, 2022 | -280,648.00 |
| Jun 30, 2022 | -189,486.00 |
| Mar 31, 2022 | -105,005.00 |
| Dec 31, 2021 | -288,027.00 |
| Sep 30, 2021 | -6.93 Mn |